Trump administration to award $354 million coronavirus drug contract to new firm

BY admin admin

US press reports on an announcement due Tuesday from the White House:
– to sign a $354 million four-year contract with a new company
– to manufacture generic medicines and pharmaceutical ingredients that are needed to treat Covid-19 but are now made overseas, mostly in India and China.
Says the NY Times

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts

Forex

The Hang Seng Index is Near Important Support

<img src="https://fxopen.com/blog/en/content/images/2024/01/hang-seng-.jpg" alt="The Hang Seng Index is Near Important Support" /><p>The economy of China is hit by the

Forex

Friday Rally On Lagarde’s Push For Fiscal Stimulus And China Pledge To US, Commodities Rally

<p>European stocks and US equity futures are climbing higher on ECB President Lagarde’s warning to EU leaders of market risks if the EU can’t quickly agree upon the EU recovery fund

Forex

COVID-19 Sends Canadian International Trade Tumbling in April

<p>Canada’s merchandise trade deficit more than doubled, to $3.3 billion in April, following a $1.5 billion deficit in March. Both exports (-29.7%) and imports (-25.1%) registered their la

Copyright © 2024 | WordPress Theme: Xews Lite